Hikma Ruling Raises Patent Pleading Bar Beyond Drug Cases
The U.S. Supreme Court's decision this month that shut down a patent suit against Hikma Pharmaceuticals USA over a drug using a so-called skinny label could also make it more challenging...To view the full article, register now.
Already a subscriber? Click here to view full article